What is Lifesci Capital’s Estimate for GLUE FY2024 Earnings?
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) – Investment analysts at Lifesci Capital issued their FY2024 earnings per share (EPS) estimates for Monte Rosa Therapeutics in a note issued to investors on Wednesday, March 12th. Lifesci Capital analyst O. Mccammon expects that the company will post earnings per share of ($2.00) for the year. […]
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) – Investment analysts at Lifesci Capital issued their FY2024 earnings per share (EPS) estimates for Monte Rosa Therapeutics in a note issued to investors on Wednesday, March 12th. Lifesci Capital analyst O. Mccammon expects that the company will post earnings per share of ($2.00) for the year. […]
